Sierra Summit Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,787
Closed -$857K 175
2024
Q3
$857K Buy
+14,787
New +$727K 0.2% 71

Other funds holding ASTH

Sierra Summit Advisors's ASTH Position: Q4 2024 in Review

Sierra Summit Advisors sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 14,787 shares — an estimated $857K sold.

Sierra Summit Advisors first reported a position in ASTH in Q3 2024 and held it in 1 quarter. The position peaked at $857K in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Sierra Summit Advisors reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Sierra Summit Advisors sold 14,787 Astrana Health shares in Q4 2024, an estimated $857K.
  • Sierra Summit Advisors first reported a position in Astrana Health in Q3 2024 and held it in 1 quarter.
  • Sierra Summit Advisors's Astrana Health position peaked at $857K in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Sierra Summit Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.